Eli Lilly to Provide Covid-19 Drug to U.S. Army
By Stephen Nakrosis
The Pentagon on Wednesday said Eli Lilly and Co. was awarded a
$625 million modification to a contract for 500,000 doses of
LY-CoV555, a Covid-19 therapeutic drug treatment.
The Pentagon said the work will be performed in Indianapolis,
Indiana, and has an estimated completion date of Jan. 27.
The U.S. Army Contracting Command, Aberdeen Proving Ground,
Maryland, is the contracting activity, the Pentagon said.
--Write to Stephen Nakrosis at firstname.lastname@example.org
(END) Dow Jones Newswires
January 27, 2021 17:52 ET (22:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.